CM
TLSIW icon

CastleKnight Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

CastleKnight Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-46,371
Closed -$84.4K – 406
2024
Q2 		$84.4K Hold
46,371
– – ﹤0.01% 346
2024
Q1 		$46.4K Hold
46,371
– – ﹤0.01% 330
2023
Q4 		$55.2K Hold
46,371
– – ﹤0.01% 299
2023
Q3 		$17.4K Hold
46,371
– – ﹤0.01% 305
2023
Q2 		$1.94K Hold
46,371
– – ﹤0.01% 299
2023
Q1 		$2.82K Hold
46,371
– – ﹤0.01% 269
2022
Q4 		$2.17K Hold
46,371
– – ﹤0.01% 222
2022
Q3 		$3K Hold
46,371
– – ﹤0.01% 224
2022
Q2 		$4K Buy
+46,371
New +$8.87K ﹤0.01% 245
2022
Q1 		– Sell
-46,371
Closed -$19.9K – 273
2021
Q4 		$24K Buy
+46,371
New +$42.6K 0.01% 187

Other funds holding TLSIW

VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CastleKnight Management's TLSIW Position: Q3 2024 in Review

CastleKnight Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 46,371 shares — an estimated $84.4K sold.

CastleKnight Management first reported a position in TLSIW in Q4 2021 and held it in 10 quarters. The position peaked at $84.4K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • CastleKnight Management reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • CastleKnight Management sold 46,371 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $84.4K.
  • CastleKnight Management first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 10 quarters.
  • CastleKnight Management's TriSalus Life Sciences Warrant position peaked at $84.4K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on CastleKnight Management's 13F filing for Q3 2024, filed 14 Nov 2024.